A detailed history of Simplex Trading, LLC transactions in Merus N.V. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,073 shares of MRUS stock, worth $97,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,073
Previous 1,903 8.93%
Holding current value
$97,824
Previous $85,000 43.53%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$39.81 - $60.2 $6,767 - $10,234
170 Added 8.93%
2,073 $122,000
Q1 2024

Apr 25, 2024

SELL
$28.03 - $51.82 $151,249 - $279,620
-5,396 Reduced 73.93%
1,903 $85,000
Q4 2023

Feb 02, 2024

BUY
$20.06 - $28.66 $131,553 - $187,952
6,558 Added 885.02%
7,299 $200,000
Q3 2023

Nov 01, 2023

BUY
$20.13 - $27.29 $14,916 - $20,221
741 New
741 $17,000
Q1 2023

Apr 27, 2023

BUY
$14.25 - $20.5 $224,822 - $323,428
15,777 New
15,777 $290,000
Q3 2022

Nov 04, 2022

BUY
$18.64 - $28.93 $12,171 - $18,891
653 New
653 $13,000
Q1 2022

May 02, 2022

SELL
$23.58 - $30.91 $52,229 - $68,465
-2,215 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$20.0 - $32.29 $44,300 - $71,522
2,215 New
2,215 $70,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.16B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.